Skip to main content
Equibles
VTRS logo

VTRS · Viatris Inc · Metrics

Track VTRS — free

Use VTRS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research VTRS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$18.45 -0.20 (-1.07%) At close · Oct 21
S&P 500 member Russell 1000 member Rebalance outlook locked
Market Cap
$21.42B
Shares
1.15B
Volume · Oct 21 10.19M Avg daily vol (3M) 9.42M

VTRS metrics

97 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$18.45
Market cap
$21.42B

Price action

20 metrics
Price change (1W)
+5.8%
Price change (30D)
+7.4%
Price change (3M)
+8.5%
Price change (6M)
+27.1%
Price change (YTD)
+48.2%
Price change (1Y)
+77.6%
Trailing year
Price change (5Y)
+31.7%
52-week high
$18.66
52-week low
$10.11
Change from 52-week high
-1.1%
Change from 52-week low
+82.5%
Annualized volatility
32.2%
Annualized volatility (3M)
27.3%
Beta
0.7
RSI (14D)
61.8
Price vs SMA 50
+7.9%
Price vs SMA 200
+17.6%
Avg volume (3M)
9.42M
Relative volume
1.1
Average dollar volume
$161.55M

Company

3 metrics
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Shares outstanding
1.15B

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
2.3×
reciprocal yield 43.5%
EV / EBITDA
12.5×
reciprocal yield 8.0%
EV / EBIT
—
P / sales
1.5×
reciprocal yield 68.8%
P / book
1.5
reciprocal yield 66.6%
FCF yield
9.1%
TTM · current market cap
Buyback yield
1.4%
P / FCF
11.0
reciprocal yield 9.1%
P / operating cash flow
9.2
reciprocal yield 10.9%
Earnings yield
-3.1%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
1.9×
reciprocal yield 51.5%
EV / revenue historical average (5Y)
2.0×
reciprocal yield 50.6%
EV / EBIT historical average (3Y)
407.3×
reciprocal yield 0.2%
EV / EBIT historical average (5Y)
267.8×
reciprocal yield 0.4%
EV / EBITDA historical average (3Y)
47.3×
reciprocal yield 2.1%
EV / EBITDA historical average (5Y)
31.7×
reciprocal yield 3.2%

Dividends & buybacks

7 metrics
Dividend yield
2.6%
Trailing 12 months
Payout ratio
—
Shareholder yield
1.4%
Dividend / share (TTM)
$0.48
Dividend growth YoY
+0.0%
Dividend growth streak
0
Last ex-dividend
2026-08-21

Earnings calendar

2 metrics
Next earnings
2026-11-05
Last earnings
2026-08-06

Profitability

9 metrics
Gross margin
34.8%
Operating margin
-0.6%
Trailing 12 months
Net margin
-24.6%
Gross profit (TTM)
$5.13B
Operating profit (TTM)
−$87.30M
Net income (TTM)
−$669.90M
Trailing 12 months
Diluted EPS (TTM)
$-0.40
FCF margin
13.3%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$0.00

Growth

11 metrics
Revenue growth YoY
+4.9%
Year over year
Net income growth YoY
—
Revenue (TTM)
$14.74B
Trailing 12 months
EPS growth YoY
—
Shares change YoY
-0.8%
Year over year · fewer shares
Revenue CAGR (3Y)
-4.2%
Revenue CAGR (5Y)
+3.7%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
-9.3%
FCF CAGR (5Y)
+14.4%

Quality

14 metrics
Return on equity
-2.9%
Return on assets
-1.1%
Debt / equity
0.9
Current ratio
1.6
EBITDA (TTM)
$2.72B
Free cash flow (TTM)
$1.95B
Quick ratio
1.0
Interest coverage
-0.2
Net debt / EBITDA
4.6
Return on invested capital
—
Trailing 12 months
Net cash
−$12.46B
Latest balance sheet
Cash & equivalents
$886.50M
Total assets
$35.04B
Total debt
$13.35B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$2.33B
Capital expenditures (TTM)
$376.00M
R&D (TTM)
$1.02B
SG&A (TTM)
$3.98B
Stock compensation (TTM)
$172.30M
R&D / revenue
6.9%
Stock compensation / revenue
1.2%

Ownership (13F)

9 metrics
13F filers
1,042
13F filer change QoQ
+8
Institutional ownership
92.2%
Conviction holders (share of 13F filers)
1.5%
Crowding (high-turnover and private-fund holders)
23.0%
Private-fund adviser ownership
21.5%
Active holders' share change QoQ
+7.2%
Holder tenure
16.6
Price vs estimated holder cost
+20.5%

Ownership (registered funds)

1 metrics
Index-fund ownership
24.3%

Short interest

3 metrics
Short interest
3.7%
Latest settlement · 4.2 days to cover
Days to cover
4.2d
Short-squeeze score
58 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1792044 CUSIP 92556V106 13F (30d) 202 filings 181 filers Visit website Investor relations